GlycoMimetics
GLYC
$1.64
Share price
-4.09%
Change (1 day)
19.71%
Change (1 year)
Categories
GlycoMimetics (GLYC) - Cash on Hand
Cash on Hand as of September 2023 : $49.4 M
According to GlycoMimetics
's latest financial reports the company has $49.4 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
GlycoMimetics - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $47.87 M | -46.96% |
| 2021-12-31 | $90.25 M | -34.14% |
| 2020-12-31 | $0.13 B | -13.38% |
| 2019-12-31 | $0.15 B | -24.64% |
| 2018-12-31 | $0.20 B | 69.39% |
| 2017-12-31 | $0.12 B | 209.49% |
| 2016-12-31 | $40.04 M | -14.45% |
| 2015-12-31 | $46.8 M | -15.21% |
| 2014-12-31 | $55.19 M | 2288.94% |
| 2013-12-31 | $2.31 M | -86.7% |
| 2012-12-31 | $17.37 M | -38.33% |
| 2011-12-31 | $28.17 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 46,303.79% | 🇺🇸 USA |
 Pfizer PFE | $12.69 B | 25,584.31% | 🇺🇸 USA |
 Sanofi SNY | $9.92 B | 19,994.36% | 🇫🇷 France |
 Palatin Technologies PTN | $9.48 M | -80.80% | 🇺🇸 USA |
 bluebird bio
BLUE | $0.17 B | 252.77% | 🇺🇸 USA |